Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Experimental Medicine Année : 2005

Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.

Résumé

Mastocytosis is a rare neoplastic disease characterized by a pathologic accumulation of tissue mast cells (MCs). Mastocytosis is often associated with a somatic point mutation in the Kit protooncogene leading to an Asp/Val substitution at position 816 in the kinase domain of this receptor. The contribution of this mutation to mastocytosis development remains unclear. In addition, the clinical heterogeneity presented by mastocytosis patients carrying the same mutation is unexplained. We report that a disease with striking similarities to human mastocytosis develops spontaneously in transgenic mice expressing the human Asp816Val mutant Kit protooncogene specifically in MCs. This disease is characterized by clinical signs ranging from a localized and indolent MC hyperplasia to an invasive MC tumor. In addition, bone marrow-derived MCs from transgenic animals can be maintained in culture for >24 mo and acquire growth factor independency for proliferation. These results demonstrate a causal link in vivo between the Asp816Val Kit mutation and MC neoplasia and suggest a basis for the clinical heterogeneity of human mastocytosis.

Domaines

Immunologie
Fichier principal
Vignette du fichier
zappulla_2005.pdf (1.6 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-00016364 , version 1 (27-02-2010)

Identifiants

Citer

Jacques P. Zappulla, Patrice Dubreuil, Sabine Desbois, Sébastien Létard, Nadine Ben Hamouda, et al.. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation.. Journal of Experimental Medicine, 2005, 202 (12), pp.1635-41. ⟨10.1084/jem.20050807⟩. ⟨hal-00016364⟩
360 Consultations
273 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More